ArticleCancer communications (London, England)2026
Enhancing Non-small Cell Lung Cancer Susceptibility to Anti-PD-1/PD-L1 Therapy through PD-L1 Ligand-Ir(III) Complex Conjugates.
Valentina Pagliara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.